[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU6514299A - Methods for the treatment of cancer using cytokines in combination with low level doses of chemotherapy and/or radiotherapy - Google Patents

Methods for the treatment of cancer using cytokines in combination with low level doses of chemotherapy and/or radiotherapy

Info

Publication number
AU6514299A
AU6514299A AU65142/99A AU6514299A AU6514299A AU 6514299 A AU6514299 A AU 6514299A AU 65142/99 A AU65142/99 A AU 65142/99A AU 6514299 A AU6514299 A AU 6514299A AU 6514299 A AU6514299 A AU 6514299A
Authority
AU
Australia
Prior art keywords
radiotherapy
chemotherapy
cytokines
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65142/99A
Inventor
Ben W. Papermaster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KINEX MEDICAL Inc
Original Assignee
KINEX MEDICAL Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KINEX MEDICAL Inc filed Critical KINEX MEDICAL Inc
Publication of AU6514299A publication Critical patent/AU6514299A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU65142/99A 1998-10-08 1999-10-07 Methods for the treatment of cancer using cytokines in combination with low level doses of chemotherapy and/or radiotherapy Abandoned AU6514299A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16878698A 1998-10-08 1998-10-08
US09168786 1998-10-08
PCT/US1999/023723 WO2000020022A1 (en) 1998-10-08 1999-10-07 Methods for the treatment of cancer using cytokines in combination with low level doses of chemotherapy and/or radiotherapy

Publications (1)

Publication Number Publication Date
AU6514299A true AU6514299A (en) 2000-04-26

Family

ID=22612924

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65142/99A Abandoned AU6514299A (en) 1998-10-08 1999-10-07 Methods for the treatment of cancer using cytokines in combination with low level doses of chemotherapy and/or radiotherapy

Country Status (2)

Country Link
AU (1) AU6514299A (en)
WO (1) WO2000020022A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8257410B2 (en) 2006-02-03 2012-09-04 The Catholic University Of America Use of weak stressors to enhance the effectiveness of ionizing radiation and other treatments of disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920196A (en) * 1982-07-30 1990-04-24 Genentech, Inc. Human lymphotoxin

Also Published As

Publication number Publication date
WO2000020022A1 (en) 2000-04-13

Similar Documents

Publication Publication Date Title
AU6276194A (en) Use of monoterpenes, sesquiterpernes and diterpernes for the treatment of cancer
AU2212299A (en) Compositions and methods for the treatment of tumor
HUS1500001I1 (en) Use of et743 in combination therapy with dexamethasone for treating cancer
AU5835098A (en) Use of pyrimidine derivatives for the prevention of cancer, on their own or in combination with other therapeutic measures
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
NZ333399A (en) Cyclooxygenase-2 inhibitors (COX-2) for the prevention and treatment of tumors, cachexia and tumor-metastasis
EP0926955A4 (en) Conjugates useful in the treatment of prostate cancer
IL129356A0 (en) Conjugates useful in the treatment of prostate cancer
HUP0004326A3 (en) Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
UA66793C2 (en) Leptin as inhibitor of tumor growth
AU2476200A (en) Ribozyme therapy for the treatment and/or prevention of restenosis
PT971710E (en) USE OF QUELERITRINA AND RADIACAO FOR TUMOR THERAPY
ZA985182B (en) Farnesyl transferase inhibitors in combination with HMG COA reductase inhibitors for the treatment of cancer.
IL141426A0 (en) Compositions and methods for the treatment of tumor
AU7856100A (en) Methods for treating solid tumors with irradiation and bacteria
AU5333298A (en) Compositions and methods for tumour therapy
WO2001034131A3 (en) Combination chemotherapy
EP1003516A4 (en) Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects
AU2506499A (en) Cea/nca-based differentiation cancer therapy
AU6514299A (en) Methods for the treatment of cancer using cytokines in combination with low level doses of chemotherapy and/or radiotherapy
AU6617498A (en) Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemo- and radiotherapy
AU1200100A (en) Inhalation chemotherapy for prevention and treatment of metastatic tumors in thelung
AU5946999A (en) Tumour therapy and imaging

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase